AUS
NZ
UK
CA
USA
IND
The A2 Milk Company Limited (ASX:A2M)
The A2 Milk Company Limited (ASX:A2M) belongs to Food, Beverage & Tobacco group of industries. The company is engaged in producing, marketing and selling the branded dairy, and infant formula products in targeted global markets.
Recently, A2M notified the change in interests for one of its directors Mr Peter Bruce Hinton. The director now owns 300,000 fully paid ordinary shares as compared to the previously held 625,000 Ordinary shares.
The company also announced the change in interests for another director Mr David Hearn. The director now owns 100,000 fully paid ordinary shares and 3,200,000 options to subscribe for fully paid ordinary shares. Previously, the director held 100,000 fully paid ordinary shares, and 3,300,000 options to subscribe for ordinary shares.
For the half-year interim results of FY19 for the period ending 31 December 2018, the company reported the revenue of NZ$613m, up by 41%. The EBITDA stood at NZ$218m up by 53%. The NPAT stood at NZ$153m, up by 55%.
The product performance is as follows:
- Liquid milk business stood at NZ$83m, up by 20%.
- Instant Formula business stood at NZ$496m, up by 45%.
- Other nutrition business stood at NZ$34m, up by 40%.
The stock of the company closed at A$14.050 (as at 7 March 2019). The company has a market capitalization of A$10.38 billion, with 733.4 million shares outstanding. The stock gave a decent return of 37.88% in the last three months and a YTD return of 36.15%.
Bellamyâs Australia Limited (ASX:BAL)
The Bellamyâs Australia Limited (ASX:BAL) belongs to Food, Beverage & Tobacco group of industries. The company is a producer and distributor of the branded food products.
Recently, the company released its 1H19 results, where the revenue was recorded at $130 million, and EBITDA result of $26 million which mainly showed the net impact of low revenue, and an enhanced gross margin. The company held on to its solid balance sheet with group cash rising to $95 million, zero debt levels, and constant access to a $40 million working capital debt facility.
The business held an increased confidence-level in the rebranding. The companyâs fresh product pipeline showed constant progress in food, and successfully got SAMR registration.
Replicating the 1H19 outcome and initial Q3 trading, the company expects complete year Group Revenue to be between $275-300M for the FY19. Â The group EBITDA for FY19 margin has been revised between 18-22% on a normalised basis.
The stock of the company settled at A$10.520 (as at 7 March 2019), up by 0.766% from its previous close. The company has a market capitalization of A$1.18 billion, with 113.37 million shares outstanding. In the last 3 months, the stock gave a return of 39.01% with strong YTD return of 37.55%.
Wattle Health Australia Limited (ASX:WHA)
The Wattle Health Australia Limited (ASX:WHA) belongs to Food, Beverage & Tobacco group of industries. It aims at offering good quality, and 100% Australian made health, and wellness products, which consumers could trust across different phases of their life.
Recently, the company notified that 59,106,250 ordinary shares would be released from escrow on 15 March 2019. The company would apply to the ASX for quotation of the mentioned number of shares on 15 March 2019 in accordance with ASX Listing Rule 2.8.2.
In its HY19 results for the six months ending 31 December 2018, the revenue for the period stood at A$363,000 with losses lessened by 66.8% to$4.3 million, from HY18 of $13.08 million. The net assets for HY19 stood at A$57.3 million, a rise of 282% from HY18 of $15 million, with working capital rising for the period by 350%. During HY19, WHA pre-purchased product from B&P, and CBDG of around $8.3 million that would derive benefits, cost savings moving ahead.
The stock of the company settled the dayâs trading at A$10.520 (as at 7 March 2019), up by 0.766% from its prior close. The company has a market capitalization of A$1.18 billion, with 113.37 million shares outstanding. In the 3 months, the stock gave a positive return of 39% with 37.55% YTD return.
Disclaimer
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
